Technical Analysis for ELDN - Eledon Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 1.62 5.19% 0.08
ELDN closed up 5.19 percent on Monday, March 18, 2024, on 69 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 28
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness 5.19%
Lower Bollinger Band Touch Weakness 5.19%
Oversold Stochastic Weakness 5.19%
20 DMA Resistance Bearish -2.99%
50 DMA Resistance Bearish -2.99%
Shooting Star Candlestick Bearish -2.99%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.99%
20 DMA Resistance Bearish -0.61%

   Recent Intraday Alerts

Alert Time
Rose Above 10 DMA about 13 hours ago
Up 1 ATR about 13 hours ago
Gap Up Closed about 14 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Rose Above Previous Day's High about 14 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Pediatrics Otorhinolaryngology Pernix Therapeutics Holdings

Is ELDN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.95
52 Week Low 1.07
Average Volume 55,671
200-Day Moving Average 1.50
50-Day Moving Average 1.75
20-Day Moving Average 1.72
10-Day Moving Average 1.65
Average True Range 0.13
RSI (14) 44.13
ADX 24.66
+DI 9.75
-DI 19.63
Chandelier Exit (Long, 3 ATRs) 1.58
Chandelier Exit (Short, 3 ATRs) 1.91
Upper Bollinger Bands 1.92
Lower Bollinger Band 1.52
Percent B (%b) 0.24
BandWidth 23.17
MACD Line -0.04
MACD Signal Line -0.02
MACD Histogram -0.0173
Fundamentals Value
Market Cap 39.2 Million
Num Shares 24.2 Million
EPS -5.44
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 0.00
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.83
Resistance 3 (R3) 1.82 1.75 1.80
Resistance 2 (R2) 1.75 1.69 1.75 1.78
Resistance 1 (R1) 1.68 1.66 1.72 1.69 1.77
Pivot Point 1.61 1.61 1.62 1.61 1.61
Support 1 (S1) 1.54 1.55 1.58 1.55 1.47
Support 2 (S2) 1.47 1.52 1.47 1.46
Support 3 (S3) 1.40 1.47 1.45
Support 4 (S4) 1.41